About This Webinar
It’s common to hear in the drugs field that if we are serious about addressing drug related harm, then policy and practice needs to be evidence-based. But what does this really mean; how is evidence used in the policy making process, and what actually counts as evidence? This talk will provide perspectives on some of the processes of drug policy development, including case examples of how political, public, and moral influences shape the creation and use of evidence. Drawing upon learning from other fields and other countries, the presentation will summarise strategies that have been used to advocate for policy change.
Presenter
  • 1602669589-2ebcb0c60f287884
    Professor Harry Sumnall
    Professor in Substance Use, Public Health Institute, Liverpool John Moores University

    Harry Sumnall is Professor in Substance Use at the Public Health Institute, Liverpool John Moores University. His research career has covered a diverse range of interests related to substance use, particularly around drug policy, evidence and guidelines, and the development and evaluation of interventions designed to reduce drug-related harms. Harry was a member of the UK Government Advisory Council on the Misuse of Drugs (ACMD) between 2011 and 2019, and he is frequently invited to undertake consultancy work for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and other international bodies. He is a former president of the European Society for Prevention Research, and a member of the Scientific Advisory Board of the Mind Foundation.
Powered by BigMarker